Log in

Midatech Pharma Stock Forecast, Price & News

+0.01 (+0.49 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $2.06
50-Day Range
MA: $1.91
52-Week Range
Now: $2.06
Volume105,411 shs
Average Volume2.17 million shs
Market Capitalization$25.98 million
P/E RatioN/A
Dividend YieldN/A
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:MTP



Sales & Book Value

Annual Sales$860,000.00
Book Value$40.82 per share



Market Cap$25.98 million
Next Earnings DateN/A
OptionableNot Optionable
+0.01 (+0.49 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTP News and Ratings via Email

Sign-up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions

How has Midatech Pharma's stock price been impacted by Coronavirus?

Midatech Pharma's stock was trading at $3.12 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MTP stock has decreased by 34.0% and is now trading at $2.06.
View which stocks have been most impacted by COVID-19

Are investors shorting Midatech Pharma?

Midatech Pharma saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 116,500 shares, a decline of 48.7% from the August 31st total of 227,100 shares. Based on an average daily trading volume, of 6,300,000 shares, the short-interest ratio is currently 0.0 days.
View Midatech Pharma's Short Interest

Who are some of Midatech Pharma's key competitors?

What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include Crispr Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), Plug Power (PLUG), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO) and Sorrento Therapeutics (SRNE).

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the following people:
  • Mr. Stephen A. Stamp, CEO, CFO & Director (Age 58)
  • Dr. Tim Sparey Ph.D., Chief Bus. Officer
  • Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing
  • Dr. Steve Damment, Exec. VP of R&D (Age 62)
  • Mr. David Benharris, Pres of Midatech Pharma US Inc (Age 55)

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

Who are Midatech Pharma's major shareholders?

Midatech Pharma's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wedbush Securities Inc. (0.11%).

Which major investors are buying Midatech Pharma stock?

MTP stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of Midatech Pharma?

Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Midatech Pharma's stock price today?

One share of MTP stock can currently be purchased for approximately $2.06.

How big of a company is Midatech Pharma?

Midatech Pharma has a market capitalization of $25.98 million and generates $860,000.00 in revenue each year. Midatech Pharma employs 65 workers across the globe.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is www.midatechpharma.com.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The company can be reached via phone at 44-12-3588-8300 or via email at [email protected]

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.